Prospects for Human Gene Therapy
- 26 October 1984
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 226 (4673) , 401-409
- https://doi.org/10.1126/science.6093246
Abstract
Procedures have now been developed for inserting functional genes into the bone marrow of mice. The most effective delivery system at present uses retroviral-based vectors to transfer a gene into murine bone marrow cells in culture. The genetically altered bone marrow is then implanted into recipient animals. These somatic cell gene therapy techniques are becoming increasingly efficient. Their future application in humans should result in at least partial correction of a number of genetic disorders. However, the safety of the procedures must still be established by further animal studies before human clinical trials would be ethical.Keywords
This publication has 77 references indexed in Scilit:
- Partial correction of murine hereditary growth disorder by germ-line incorporation of a new geneNature, 1984
- Lack of site specific recombination of exogenous DNA in mouse L cellsBiochemical and Biophysical Research Communications, 1983
- Retrovirus transfer of a bacterial gene into mouse haematopoietic progenitor cellsNature, 1983
- Regulated expression of the human β-globin gene family in murine erythroleukaemia cellsNature, 1983
- The regulated expression of β-globin genes introduced into mouse erythroleukemia cellsCell, 1983
- Induction of mouse erythroleukemia cells by microinjection of inducing compoundExperimental Cell Research, 1981
- The Potentials of Inserting New Genetic InformationNew England Journal of Medicine, 1980
- Gene Therapy in Human Beings: When Is It Ethical to Begin?New England Journal of Medicine, 1980
- Insertion of a New Gene of Viral Origin into Bone Marrow Cells of MiceScience, 1980
- Gene transfer in intact animalsNature, 1980